Literature DB >> 17166521

Quantitative structure-activity relationship (QSAR) for neuroprotective activity of terpenoids.

Hyun-Joo Chang1, Hyun Jung Kim, Hyang Sook Chun.   

Abstract

Neuroprotective activity of thirteen terpenoids on human neuroblastoma SH-SY5Y was evaluated in vitro by using a simulated ischemia model. The protective effects on ischemic damage ranged from 3.0% to 56.5%, and trans-4,11,11-trimethyl-8-methylenebicyclo[7,2,0]undec-4-ene (trans-caryophyllene) showed the highest neuroprotective activity. A quantitative structure-activity relationship (QSAR) model was developed for eleven terpenoids with significant neuroprotective activity using TSAR software. The QSAR study produced two equations with significant predictive values (r(2) and p value) and indicated that the activity was mainly governed by lipophilicity, shape index, and electrostatic property. This QSAR approach can contribute to a better understanding of structural properties of the terpenoids responsible for neuroprotection, and can be useful in predicting the neuroprotective activity of other terpenoids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17166521     DOI: 10.1016/j.lfs.2006.11.009

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Trans-caryophyllene suppresses hypoxia-induced neuroinflammatory responses by inhibiting NF-κB activation in microglia.

Authors:  Kexin Guo; Xiaojie Mou; Jinsha Huang; Nian Xiong; Hongge Li
Journal:  J Mol Neurosci       Date:  2014-02-04       Impact factor: 3.444

2.  Neuroprotective effects of trans-caryophyllene against kainic acid induced seizure activity and oxidative stress in mice.

Authors:  Hao Liu; Zhi Song; Daguang Liao; Tianyi Zhang; Feng Liu; Kai Zhuang; Kui Luo; Liang Yang
Journal:  Neurochem Res       Date:  2014-11-23       Impact factor: 3.996

3.  β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease.

Authors:  Shreesh Ojha; Hayate Javed; Sheikh Azimullah; M Emdadul Haque
Journal:  Mol Cell Biochem       Date:  2016-06-17       Impact factor: 3.396

Review 4.  Bioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases.

Authors:  Mariana Barbosa; Patrícia Valentão; Paula B Andrade
Journal:  Mar Drugs       Date:  2014-09-25       Impact factor: 5.118

5.  High membrane protein oxidation in the human cerebral cortex.

Authors:  Matthias Granold; Bernd Moosmann; Irina Staib-Lasarzik; Thomas Arendt; Adriana Del Rey; Kristin Engelhard; Christian Behl; Parvana Hajieva
Journal:  Redox Biol       Date:  2014-12-24       Impact factor: 11.799

6.  Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease.

Authors:  Hayate Javed; Sheikh Azimullah; M Emdadul Haque; Shreesh K Ojha
Journal:  Front Neurosci       Date:  2016-08-02       Impact factor: 4.677

Review 7.  Essential Oils as Repellents against Arthropods.

Authors:  Mi Young Lee
Journal:  Biomed Res Int       Date:  2018-10-02       Impact factor: 3.411

8.  Neurotropic activity and safety of methylene-cycloalkylacetate (MCA) derivative 3-(3-allyl-2-methylenecyclohexyl) propanoic acid.

Authors:  Adi Lahiani; Dikla Haham-Geula; David Lankri; Susan Cornell-Kennon; Erik M Schaefer; Dmitry Tsvelikhovsky; Philip Lazarovici
Journal:  ACS Chem Neurosci       Date:  2020-08-03       Impact factor: 4.418

9.  Assessment of Anticholinesterase Activity of Gelidiella acerosa: Implications for Its Therapeutic Potential against Alzheimer's Disease.

Authors:  Arif Nisha Syad; Karutha Pandian Shunmugiah; Pandima Devi Kasi
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-06       Impact factor: 2.629

10.  Essential Oils in Experimental Models of Neuropsychiatric Disorders: A Systematic Review.

Authors:  Luciana Cristina B Fernandes; Ianara Mendonça Costa; Marco Aurelio M Freire; Francisca Overlânia V Lima; Francisca Idalina Neta; Eudes Euler de Souza Lucena; Rodrigo Dias Alves; Jose Rodolfo Lopes P Cavalcanti; Francisco Irochima Pinheiro; Eduardo Pereira de Azevedo; Carlos Iberê A Freitas; Fausto Pierdoná Guzen
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.